Home/Filings/4/0001140361-22-009654
4//SEC Filing

Esfandiari Javan 4

Accession 0001140361-22-009654

CIK 0001092662other

Filed

Mar 14, 8:00 PM ET

Accepted

Mar 15, 9:30 PM ET

Size

10.1 KB

Accession

0001140361-22-009654

Insider Transaction Report

Form 4
Period: 2022-03-11
Esfandiari Javan
Senior Vice President
Transactions
  • Award

    Incentive Stock Options

    2021-03-11+69,43569,435 total
    Exercise: $1.25Exp: 2032-03-10Common Stock (69,435 underlying)
  • Award

    Nonqualified Stock Options

    2021-03-11+208,279208,281 total
    Exercise: $1.25Exp: 2032-03-10Common Stock (208,281 underlying)
  • Award

    Restricted Stock Units

    2021-03-11+144,000144,000 total
    Common Stock (144,000 underlying)
Footnotes (4)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of common stock.
  • [F2]On March 16, 2020, the reporting person was granted 144,000 restricted stock units scheduled to vest in equal installments on March 11 of each of 2023, 2024 and 2025, subject to continued service through each vesting date.
  • [F3]The incentive stock options are scheduled to vest and become exercisable over four years, with two shares vesting on March 11, 2023, two shares vesting on March 11, 2024, two shares vesting on March 11, 2025 and the remaining 69,429 shares vesting on March 11, 2026, subject to continued service through each vesting date.
  • [F4]The nonqualified stock options are scheduled to vest and become exercisable over three years, with 69,426 shares vesting on March 11, 2023, 69,427 shares vesting on March 11, 2024, and 69,426 shares vesting on March 11, 2025, subject to continued service through each vesting date.

Issuer

CHEMBIO DIAGNOSTICS, INC.

CIK 0001092662

Entity typeother

Related Parties

1
  • filerCIK 0001397402

Filing Metadata

Form type
4
Filed
Mar 14, 8:00 PM ET
Accepted
Mar 15, 9:30 PM ET
Size
10.1 KB